Douglas Flora: It was an absolute pleasure to interview one of my idols, Dr. Karen Knudsen

Douglas Flora shared a post on LinkedIn:

“Ahead of Print:

It was an absolute pleasure to interview one of my idols, Dr. Karen Knudsen, CEO of the American Cancer Society, for our upcoming June issue of AI in Precision Oncology. As many of us gear up for ASCO ’24 in Chicago, where AI and Precision Medicine will be key topics of discussion, her insights couldn’t be more timely.

Dr. Knudsen shared her vision of how AI can revolutionize cancer care, improve early detection and personalized treatment plans, and enhance patient outcomes. She emphasized the importance of integrating AI technologies responsibly and ethically to ensure they truly benefit patients.

To read more about our enlightening conversation, check out the full interview here: AI and ACS: An Interview with Karen Knudsen. ”

Source: Douglas Flora/LinkedIn

Dr. Douglas Flora, MD, is a medical oncologist based in Edgewood, Kentucky, with over 24 years of dedicated service in the field. Graduating from the Ohio State University College of Medicine in 1999, Dr. Flora has since become a respected figure in oncology, affiliated with leading hospitals such as St. Elizabeth Healthcare Edgewood-Covington Hospitals and St. Elizabeth Fort Thomas Hospital.

With a background in hematology and medical oncology, Dr. Flora serves as the Chief of the Division of Medical Oncology and Hematology at the TriHealth Cancer Institute in Cincinnati, Ohio. He specializes in treating various cancers, including breast, lung, and gastrointestinal malignancies, utilizing innovative treatment approaches backed by clinical research.

Beyond patient care, Dr. Flora is dedicated to medical education, mentoring future oncologists and contributing to research initiatives aimed at improving patient outcomes. His commitment to excellence and compassionate care underscores his significant impact in the fight against cancer.